Letters
Lack of funding will inhibit evidence based commissioning of cancer treatments
BMJ 2000; 320 doi: https://doi.org/10.1136/bmj.320.7226.54 (Published 01 January 2000) Cite this as: BMJ 2000;320:54
- June So, chief pharmacist,
- J Howard Scarffe, professor of medical oncology,
- Elizabeth Rous, consultant in public health medicine,
- Robbie Foy, clinical research fellow (R.Foy@ed.ac.uk)
- Christie Hospital NHS Trust, Manchester M20 4BX
- Manchester Health Authority, Gateway House, Manchester M60 7LP
- Scottish Programme for Clinical Effectiveness in Reproductive Health, Department of Obstetrics and Gynaecology, University of Edinburgh, Edinburgh EH3 9AW
EDITOR—We welcome the appointment of a cancer tsar to improve the treatment of patients with cancer in the NHS.1 However, more resources and greater transparency in their allocation will be necessary to improve survival rates in the United Kingdom in relation to its …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £164 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£30 / $37 / €33 (excludes VAT)
You can download a PDF version for your personal record.